ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 83565 | ISO 21474-3:2024 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 3: Interpretation and reports | Standarts spēkā |
| 81712 | ISO/TS 5798:2022 | In vitro diagnostic test systems — Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods | Standarts spēkā |
| 81506 | ISO 5649:2024 | Medical laboratories — Concepts and specifications for the design, development, implementation and use of laboratory-developed tests | Standarts spēkā |
| 72191 | ISO 15190:2020 | Medical laboratories — Requirements for safety | Standarts spēkā |
| 87680 | ISO/TS 22583:2024 | Requirements and recommendations for supervisors and operators of point-of-care testing (POCT) equipment | Standarts spēkā |
| 78024 | ISO 21474-2:2022 | In vitro diagnostic medical devices — Multiplex molecular testing for nucleic acids — Part 2: Validation and verification | Standarts spēkā |
| 85349 | ISO 18704:2026 | Molecular in vitro diagnostic examinations — Requirements and recommendations for pre-examination processes for urine and other body fluids — Isolated cell-free DNA | Standarts spēkā |
| 77070 | ISO/TS 23824:2024 | Medical laboratories — Guidance on application of ISO 15189 in anatomic pathology | Standarts spēkā |
| 79377 | ISO 20776-2:2021 | Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution | Standarts spēkā |
| 69799 | ISO 20186-2:2019 | Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for venous whole blood — Part 2: Isolated genomic DNA | Standarts spēkā |
Displaying 1-10 of 146 results.